Viewing Study NCT05624606


Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2026-02-24 @ 2:06 PM
Study NCT ID: NCT05624606
Status: COMPLETED
Last Update Posted: 2025-03-18
First Post: 2022-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module